New vaccine shows promise in protecting against common cause of meningitis

Researc hers are an important step closer to finding a vaccine that protects against a wide range of strains of meningococcal B – the most common cause of meningococcal disease in Western Australia.

New research published Online First in The Lancet Infectious Diseases showed the trials of the potential vaccine had found it to be safe and that it stimulated an effective immune response.

The report’s author Associate Professor Peter Richmond heads the Vaccine Trials Group, a collaboration between the Telethon Institute for Child Health

Research and Princess Margaret Hospital. Leer más